MTNB - Matinas BioPharma Holdings, Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 0.1756

Open

$ 0.17

Bid

$ 0.18 x 100

Ask

$ 0.00 x 0

Day's Range

$ 0.17 - $ 0.18

52 Week Range

$ 0.11 - $ 0.89

Volume

1,285,443

Average Volume

Market Cap

38.17M

Beta (5Y Monthly)

$ 1.22

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-27-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-09-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	03-15-2023	12-31-2022	10-K
7	11-02-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-08-2022	12-31-2021	10-K
11	11-08-2021	09-30-2021	10-Q
12	08-10-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	03-29-2021	12-31-2020	10-K
15	11-06-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-11-2020	03-31-2020	10-Q
18	03-09-2020	12-31-2019	10-K
19	11-13-2019	09-30-2019	10-Q
20	08-13-2019	06-30-2019	10-Q
21	05-13-2019	03-31-2019	10-Q
22	04-01-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-09-2018	03-31-2018	10-Q
26	03-16-2018	12-31-2017	10-K
27	11-14-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-15-2017	03-31-2017	10-Q
30	03-31-2017	12-31-2016	10-K
31	11-14-2016	09-30-2016	10-Q
32	08-15-2016	06-30-2016	10-Q
33	05-13-2016	03-31-2016	10-Q
34	03-30-2016	12-31-2015	10-K
35	11-10-2015	09-30-2015	10-Q
36	08-13-2015	06-30-2015	10-Q
37	05-15-2015	03-31-2015	10-Q
38	03-31-2015	12-31-2014	10-K
39	11-14-2014	09-30-2014	10-Q
40	08-08-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Matinas BioPharma Hldgs Q1 2024 GAAP EPS $...
05/09/2024 21:25:03

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate.

Matinas BioPharma's LNC Platform For The D...
05/07/2024 12:04:05

Matinas BioPharma Holdings, Inc. (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking t...

In Vivo Efficacy Of Matinas BioPharma's Or...
04/30/2024 12:16:11

Matinas BioPharma Holdings, Inc. (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking t...

Matinas BioPharma Prices $10M Registered D...
04/03/2024 12:34:25

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
04/01/2024 20:31:02

Matinas BioPharma Hldgs Q4 EPS $(0.03) Dow...
03/28/2024 03:42:17

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share. This is a 50 percent decrease over losses o...

Matinas BioPharma FY23 EPS $(0.11) Vs $(0....
03/27/2024 20:34:06

2023 Financial ResultsRevenue for 2023 was $1.1 million, which was generated from the Company's research collaborations wit...

Matinas BioPharma Announces Results From A...
03/25/2024 12:16:11

why-is-fungal-infections-focused-matinas-biopharma-stock-trading-higher-on-friday

Why Is Fungal Infections-Focused Matinas B...
03/22/2024 14:37:35

Progress with Matinas BioPharma's MAT2203 for invasive fusarium infection. Clinical response achieved in patients resistant...

Matinas BioPharma Announces Complete Clini...
03/22/2024 13:16:49

Matinas BioPharma Regains Compliance With ...
03/22/2024 10:31:41

Matinas BioPharma Provides Update On MAT22...
02/26/2024 13:04:41

A total of 19 patients with serious/life-threatening invasive fungal infections have been enrolled, including aspergillosis, mu...

Matinas BioPharma Reaches Agreement with F...
02/20/2024 12:31:13

Matinas BioPharma (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using ...

why-reneo-pharmaceuticals-shares-are-trading-higher-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Reneo Pharmaceuticals Shares Are Tradi...
12/27/2023 19:11:57

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an ac...

why-is-inflammatory-focused-matinas-biopharma-stock-trading-higher-today

Why Is Inflammatory Focused Matinas BioPha...
12/27/2023 16:02:16

Wednesday, Matinas BioPharma Holdings Inc (NASDAQ: MTNB) announced results from a series of in vivo studies demonstrating succe...

Matinas BioPharma Reports Results From Ser...
12/27/2023 12:32:57

In an acute colitis model, data show statistically significant knockdown of elevated levels of serum TNFα, reductions in tissue...

Matinas BioPharma Updates on MAT2203 Regul...
12/21/2023 12:31:23

Matinas BioPharma Holdings, Inc. (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking t...

Matinas BioPharma Hldgs Q3 2023 EPS $(0.03...
11/08/2023 22:01:30

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. Th...

Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

Matinas BioPharma Hldgs's Earnings: A Preview
11/07/2023 18:02:10